Ledipasvir/Sofosbuvir Eradicates Hepatitis C in an Immunodeficient STAT3-GOF Patient

J Clin Immunol. 2021 Aug;41(6):1365-1367. doi: 10.1007/s10875-021-01011-9. Epub 2021 Mar 29.
No abstract available

Publication types

  • Case Reports
  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antiviral Agents / therapeutic use*
  • Benzimidazoles / therapeutic use*
  • Child
  • Female
  • Fluorenes / therapeutic use*
  • Gain of Function Mutation / genetics*
  • Genotype
  • Hepatitis C / drug therapy*
  • Hepatitis C / genetics*
  • Humans
  • STAT3 Transcription Factor / genetics*
  • Sofosbuvir / therapeutic use*

Substances

  • Antiviral Agents
  • Benzimidazoles
  • Fluorenes
  • STAT3 Transcription Factor
  • STAT3 protein, human
  • ledipasvir, sofosbuvir drug combination
  • ledipasvir
  • Sofosbuvir